论文部分内容阅读
目的探讨双歧三联活菌片联合蒙脱石散治疗小儿腹泻的临床疗效。方法选取梧州市红十字医院2014—2016年收治的小儿腹泻患者120例,随机分为对照组和试验组,各60例。对照组患儿采取常规对症治疗,试验组患儿在对照组基础上给予双歧三联活菌片联合蒙脱石散治疗,两组患儿均以1周为1个疗程,持续治疗2周。比较两组患儿临床疗效、排便恢复时间、腹痛改善时间、呕吐改善时间及家属治疗满意度。结果试验组患儿治疗总有效率、家属治疗满意度高于对照组(P<0.05)。试验组患儿排便恢复时间、腹痛改善时间及呕吐改善时间短对照组(P<0.05)。结论采用双歧三联活菌片联合蒙脱石散治疗小儿腹泻的临床疗效确切,可有效改善患儿的临床症状,提高家属满意度。
Objective To investigate the clinical effects of live bifidobacterium tablets combined with montmorillonite powder in the treatment of children with diarrhea. Methods 120 cases of infantile diarrhea admitted to Wuzhou Red Cross Hospital from 2014 to 2016 were randomly divided into control group and trial group, with 60 cases each. Children in the control group were treated with conventional symptomatic treatment. The children in the experimental group were treated with live bifidobacterium tablets combined with montmorillonite powder on the basis of the control group. Both groups were given 1 course of treatment for 1 week and continued for 2 weeks. The clinical efficacy, defecation recovery time, abdominal pain improvement time, vomiting improvement time and relatives’ family satisfaction were compared between the two groups. Results The total effective rate of treatment in children in trial group was higher than that in control group (P <0.05). The defecation recovery time, abdominal pain improvement time and vomiting improvement time in the experimental group were shorter than those in the control group (P <0.05). Conclusions The clinical efficacy of bifid triple viable mononuclear cells combined with montmorillonite powder for the treatment of children with diarrhea is definite, which can effectively improve the clinical symptoms and improve the satisfaction of family members.